What are the European Respiratory Society (ERS) guidelines long-term antibiotic treatment regimens for bronchiectasis?

Updated: Jul 23, 2019
  • Author: Ethan E Emmons, MD; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print
Answer

Offer long-term antibiotic treatment for adults with bronchiectasis who have three or more exacerbations per year, as follows:

  • Long-term treatment with inhaled antibiotic for adults with bronchiectasis and chronic P aeruginosa infection
  • Long-term treatment with macrolides (azithromycin, erythromycin) for adults with bronchiectasis and chronic P aeruginosa infection in whom inhaled antibiotic is contraindicated, not tolerated, or not feasible
  • Long-term treatment with macrolides (azithromycin, erythromycin) in addition to, or in place of, inhaled antibiotic for adults with bronchiectasis and chronic P aeruginosa infection who have a high exacerbation frequency despite taking inhaled antibiotic
  • Long-term treatment with macrolides (azithromycin, erythromycin) for adults with bronchiectasis not infected with P aeruginosa
  • Long-term treatment with oral antibiotic (selection based on antibiotic susceptibility and patient tolerance) for adults with bronchiectasis not infected with P aeruginosa in whom macrolides are contraindicated, not tolerated, or ineffective
  • Long-term treatment with inhaled antibiotic for adults with bronchiectasis not infected with P aeruginosa in whom oral antibiotic prophylaxis is contraindicated, not tolerated, or ineffective

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!